NeoStem Inc (NBS): Neostem Stands To Benefit From Stem-Cell DealsSeeking AlphaThe age of stem cell acceptance has arrived. Last week shares of OncoMed Pharmaceuticals, Inc. (OMED) soared over 100%, moving from a $14.00 close on December 2nd to an intraday high of $32.39 on December 4th. The news that drove shares this high read [ ]
http://blog.zandcell.com/neostem-inc-nbs-neostem-stands-to-benefit-from-stem-cell-deals-seeking-alpha/?utm_source=rss&utm_medium=rss&utm_campaign=neostem-inc-nbs-neostem-stands-to-benefit-from-stem-cell-deals-seeking-alpha
Inga kommentarer:
Skicka en kommentar